Kopran

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE082A01010
  • NSEID: KOPRAN
  • BSEID: 524280
INR
118.90
5.2 (4.57%)
BSENSE

Mar 20

BSE+NSE Vol: 2.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 568367,
    "name": "Kopran",
    "stock_name": "Kopran",
    "full_name": "Kopran Ltd",
    "name_url": "stocks-analysis/kopran",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "118.90",
    "chg": 5.2,
    "chgp": "4.57%",
    "dir": 1,
    "prev_price": "113.70",
    "mcapval": "573.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524280,
    "symbol": "KOPRAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE082A01010",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "2.36 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kopran-568367-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kopran Ltd Stock Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-hits-52-week-low-amid-continued-downtrend-3893561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3893561.png",
        "date": "2026-03-16 10:52:07",
        "description": "Kopran Ltd’s shares declined to a fresh 52-week low of Rs.112.1 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting a series of financial setbacks and subdued performance metrics over recent quarters."
      },
      {
        "title": "Kopran Ltd Stock Falls to 52-Week Low of Rs.115.65 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-falls-to-52-week-low-of-rs11565-amid-continued-downtrend-3890119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3890119.png",
        "date": "2026-03-13 19:28:48",
        "description": "Kopran Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.115.65 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics."
      },
      {
        "title": "Kopran Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-is-rated-strong-sell-3882314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_mojoScore_3882314.png",
        "date": "2026-03-10 10:10:50",
        "description": "Kopran Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Kopran Ltd Stock Falls to 52-Week Low Amid Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-stock-falls-to-52-week-low-amid-continued-underperformance-3880001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_priceRelatedfactors_3880001.png",
        "date": "2026-03-09 12:31:35",
        "description": "Kopran Ltd’s shares declined to a fresh 52-week low of Rs.115.75 on 9 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and the broader market, reflecting persistent challenges in financial performance and market sentiment."
      },
      {
        "title": "Kopran Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-bearish-signals-3868177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KopranLtd_technicaldot_3868177.png",
        "date": "2026-03-04 08:03:17",
        "description": "Kopran Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite some mildly bullish signals on weekly MACD and KST, the overall technical landscape remains challenging, reflecting in the company’s downgraded Mojo Grade to Strong Sell and a significant price decline in early March 2026."
      },
      {
        "title": "Kopran Ltd Gains 1.19% Despite Strong Sell Downgrade: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-gains-119-despite-strong-sell-downgrade-3-key-factors-driving-the-week-3862579",
        "imagepath": "",
        "date": "2026-02-28 16:02:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 23:</strong> Stock opens at Rs.128.65, down 1.00% amid Sensex gains</p>\n                    <p><strong>Feb 24:</strong> Price unchanged at Rs.128.65 despite Sensex decline</p>\n                    <p><strong>Feb 25:</strong> Price rises 0.86% to Rs.129.75, technical momentum shifts</p>\n                    <p><strong>Feb 26:</strong> Mojo Grade downgraded to Strong Sell; price jumps 2.62% to Rs.133.15</p>\n                    <p><strong>Feb 27:</strong> Mixed technical signals as price retreats 1.24% to Rs.131.50</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-va..."
      },
      {
        "title": "Kopran Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-mixed-market-signals-3859518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KopranLtd_technicaldot_3859518.png",
        "date": "2026-02-27 08:01:27",
        "description": "Kopran Ltd, a Pharmaceuticals & Biotechnology micro-cap, has exhibited a nuanced shift in technical momentum as recent data reveals a transition from a strongly bearish stance to a mildly bearish trend. Despite a modest 2.5% gain in the latest session, the company’s technical indicators present a mixed picture, underscoring the challenges faced in reversing longer-term downtrends amid sectoral headwinds and broader market dynamics."
      },
      {
        "title": "Kopran Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3857438",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KopranLtd_mojoScore_3857438.png",
        "date": "2026-02-26 08:16:26",
        "description": "Kopran Ltd, a player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 25 Feb 2026. This revision reflects deteriorating financial performance, bearish technical indicators, and subdued valuation metrics, signalling heightened caution for investors amid ongoing challenges."
      },
      {
        "title": "Kopran Ltd Technical Momentum Shifts Amid Bearish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-ltd-technical-momentum-shifts-amid-bearish-outlook-3857278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KopranLtd_technicaldot_3857278.png",
        "date": "2026-02-26 08:01:19",
        "description": "Kopran Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a modest day gain of 0.86%, the stock’s broader technical landscape and fundamental metrics suggest caution for investors amid sector headwinds and underperformance relative to the Sensex."
      }
    ],
    "total": 283,
    "sid": "568367",
    "stock_news_url": "https://www.marketsmojo.com/news/kopran-568367"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "17-Mar-2026",
      "details": "Resignation of Non Executive Non- Independent Director Mr. Adarsh Somani (DIN:00192609)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
      "datetime": "28-Feb-2026",
      "details": "Observation letter from NSE",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
      "datetime": "27-Feb-2026",
      "details": "Observation Letter with no adverse observations from Bombay Stock Exchange of India (BSE Limited) on Scheme of Amalgamation Received.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Kopran Ltd Gains 1.19% Despite Strong Sell Downgrade: 3 Key Factors Driving the Week

2026-02-28 16:02:35

Key Events This Week

Feb 23: Stock opens at Rs.128.65, down 1.00% amid Sensex gains

Feb 24: Price unchanged at Rs.128.65 despite Sensex decline

Feb 25: Price rises 0.86% to Rs.129.75, technical momentum shifts

Feb 26: Mojo Grade downgraded to Strong Sell; price jumps 2.62% to Rs.133.15

Feb 27: Mixed technical signals as price retreats 1.24% to Rs.131.50

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Resignation of Director

17-Mar-2026 | Source : BSE

Resignation of Non Executive Non- Independent Director Mr. Adarsh Somani (DIN:00192609)

Announcement under Regulation 30 (LODR)-Scheme of Arrangement

28-Feb-2026 | Source : BSE

Observation letter from NSE

Announcement under Regulation 30 (LODR)-Scheme of Arrangement

27-Feb-2026 | Source : BSE

Observation Letter with no adverse observations from Bombay Stock Exchange of India (BSE Limited) on Scheme of Amalgamation Received.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kopran Ltd has declared 30% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available